These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8024823)

  • 1. [Prognostic factors in multiple sclerosis in a population-based series in Asturias].
    Uría DF; Menes BB; Calatayud MT; Arribas JM
    Neurologia; 1994 May; 9(5):182-7. PubMed ID: 8024823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Late onset multiple sclerosis].
    Delalande S; De Seze J; Ferriby D; Stojkovic T; Vermersch P
    Rev Neurol (Paris); 2002 Nov; 158(11):1082-7. PubMed ID: 12451340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is late-onset multiple sclerosis associated with a worse outcome?
    Tremlett H; Devonshire V
    Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis in Australia: prognostic factors.
    Hammond SR; McLeod JG; Macaskill P; English DR
    J Clin Neurosci; 2000 Jan; 7(1):16-9. PubMed ID: 10847644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
    J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in multiple sclerosis.
    Bergamaschi R
    Int Rev Neurobiol; 2007; 79():423-47. PubMed ID: 17531853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population.
    El-Salem K; Khader Y
    Clin Neurol Neurosurg; 2007 Jan; 109(1):32-7. PubMed ID: 16870328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pars planitis: clinical features and class II HLA associations.
    Raja SC; Jabs DA; Dunn JP; Fekrat S; Machan CH; Marsh MJ; Bressler NM
    Ophthalmology; 1999 Mar; 106(3):594-9. PubMed ID: 10080220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Young-onset multiple sclerosis].
    Silva A; Sá MJ
    Rev Neurol; 1999 Jun 1-15; 28(11):1036-40. PubMed ID: 10390767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica.
    Ghezzi A; Bergamaschi R; Martinelli V; Trojano M; Tola MR; Merelli E; Mancardi L; Gallo P; Filippi M; Zaffaroni M; Comi G;
    J Neurol; 2004 Jan; 251(1):47-52. PubMed ID: 14999489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DR15 is associated with lower age at onset in multiple sclerosis.
    Masterman T; Ligers A; Olsson T; Andersson M; Olerup O; Hillert J
    Ann Neurol; 2000 Aug; 48(2):211-9. PubMed ID: 10939572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis.
    Ramagopalan SV; Byrnes JK; Dyment DA; Guimond C; Handunnetthi L; Disanto G; Yee IM; Ebers GC; Sadovnick AD
    J Hum Genet; 2009 Sep; 54(9):547-9. PubMed ID: 19629136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of multiple sclerosis: clinical factors predicting the late evolution for an early treatment decision.
    Bergamaschi R
    Expert Rev Neurother; 2006 Mar; 6(3):357-64. PubMed ID: 16533140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Survival in amyotrophic lateral sclerosis].
    Alcaz S; Jarebinski M; Pekmezović T; Marinković Z; Apostolski S
    Srp Arh Celok Lek; 1997; 125(1-2):19-23. PubMed ID: 17974351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood-juvenile multiple sclerosis: clinical characteristics and treatment.
    Ghezzi A
    Expert Rev Neurother; 2005 May; 5(3):403-11. PubMed ID: 15938673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of 70 neuropathologic cases of multiple sclerosis].
    Izquierdo G; Hauw JJ; Lyon-Caen O; Marteau R; Escourolle R; Buge A; Castaigne P; Lhermitte F
    Rev Neurol (Paris); 1985; 141(8-9):546-52. PubMed ID: 4089416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of histocompatibility antigens distribution in patients with multiple sclerosis].
    Shiralieva RK; Guseĭnova KA
    Klin Med (Mosk); 1998; 76(1):19-20. PubMed ID: 9532908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis.
    Minneboo A; Barkhof F; Polman CH; Uitdehaag BM; Knol DL; Castelijns JA
    Arch Neurol; 2004 Feb; 61(2):217-21. PubMed ID: 14967769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.